News | July 08, 2022
Evonik launches non-animal-derived collagen platform for medical device applications
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
Subscribe To Our Newsletter & Stay Updated
